CryoLife's next-gen hemodialysis device gains 510(k) clearance

04/5/2013 | RTT News

The FDA has cleared CryoLife to market its Hemodialysis Reliable Outflow, or HeRO, system. The next-generation device, set to be released in the fourth quarter, provides long-term AV access for central venous stenosis patients undergoing hemodialysis and improves on the original version with an adaptor for integration with other dialysis access grafts.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY